In addition, neutral sphingomyelinase 2 (nSMase2)-dependent EC activation has been shown to express chemokines, CX3CL1 and CXCL10, as well as the adhesion molecule VCAM1, to promote T cell migration into the tumor bed. This evidence concerns the gene CXCL10 and neoplasm.